CoChat

Efficacy of Digital Speech Therapy for Poststroke Dysarthria: Randomized Noninferiority Trial

Open access

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 6 of the 29 sources its claims cite were checked for support.

Abstract

Background: Poststroke dysarthria, a common speech impairment, affects up to half of all stroke survivors, often reducing their ability to communicate, and adversely affecting their quality of life. Although conventional speech therapy for poststroke dysarthria is effective, access is often limited by time and geographical constraints. Here, digital speech therapy may serve as a remotely deliverable alternative for selected patients. However, few trials have assessed its efficacy, safety, and usability. Objective: This study aimed to evaluate whether a smartphone-based speech therapy app is noninferior to conventional workbook-based therapy in improving speech intelligibility among individuals with poststroke dysarthria. Methods: This single-blind, randomized controlled, noninferiority trial was performed at 3 hospitals in South Korea. Adults (≥19 y) with poststroke dysarthria who were cognitively intact, without aphasia, and able to use a smartphone were eligible. Participants were enrolled between July 20, 2023, and April 15, 2024. Participants were randomly assigned (1:1), stratified by stroke phase, using a block randomization method, to receive either a smartphone-based digital therapy app or a conventional workbook-based therapy for 4 weeks. The primary outcome was speech intelligibility (0-100 perceptual rating) after the intervention. Primary analysis was intention-to-treat using analysis of covariance. A noninferiority margin of 19 points was pre-defined. Results: A total of 73 participants were enrolled (median age 62.00 years). Among them, 38 were assigned to the digital speech therapy group and 35 to the control group. Intelligibility scores improved from 80.48 (SD 18.92) to 92.08 (SD 12.38) in the intervention group, and from 80.94 (SD 16.74) to 88.11 (SD 18.06) in the control group. The adjusted between-group difference was 4.49 (95% CI 0.61-8.37), and the lower bound of the 95% CI was above the prespecified noninferiority margin (-19), which supported noninferiority. No significant between-group differences were observed in the secondary outcomes related to speech function or psychological status. The system usability score was 89.6, and adherence in the digital speech therapy group was 64.6% based on app logs, with no treatment-related adverse events. Conclusions: Digital speech therapy was noninferior to conventional workbook-based therapy in improving speech intelligibility and was feasible across acute to early subacute and chronic stroke phases in cognitively intact stroke survivors with predominantly mild-to-moderate dysarthria. However, feasibility and efficacy in older stroke survivors with cognitive deficits or co-occurring aphasia, or in those unable to use smartphones, remain to be established.

Overview

CoChat Summary

TL;DR

In a multicenter randomized noninferiority trial, a smartphone-based digital speech therapy app was noninferior to conventional workbook-based therapy for improving speech intelligibility in poststroke dysarthria. The adjusted between-group difference was 4.49 points (95% CI 0.61-8.37), with the lower CI bound above the prespecified –19-point margin.

Key findings

  • Speech intelligibility improved from 80.48 (SD 18.92) to 92.08 (SD 12.38) in the digital therapy group and from 80.94 (SD 16.74) to 88.11 (SD 18.06) in the control group; the adjusted mean difference was 4.49 (95% CI 0.61-8.37), supporting noninferiority.
  • No significant between-group differences were found for secondary speech function or psychological outcomes, including MPT (0.82, 95% CI –1.26 to 2.91; P=.43), PCC (0.14, 95% CI –1.82 to 2.10; P=.88), PHQ-9 (–1.02, 95% CI –3.16 to 1.13; P=.35), and QoL-Dys total (–3.04, 95% CI –14.72 to 8.65; P=.61).
  • Usability in the digital group was high (mean SUS 89.57, SD 10.70), adherence was 64.6% by app logs, and no treatment-related adverse events were reported.
  • Per-protocol analysis (n=46) showed an adjusted difference of 3.57 (95% CI –1.79 to 8.92), also above the noninferiority margin.

Methods

  • Multicenter, prospective, evaluator-blinded, randomized controlled noninferiority trial at 3 hospitals in South Korea; 73 adults with poststroke dysarthria were randomized 1:1 to smartphone-based digital therapy (n=38) or conventional workbook-based therapy (n=35), stratified by stroke phase.
  • Eligible participants were ≥19 years, cognitively intact (MMSE ≥26), without aphasia, and able to use a smartphone; both groups were prescribed 60 minutes/day, 5 days/week for 4 weeks.
  • Primary outcome was speech intelligibility (0-100 perceptual rating) after intervention, assessed from the Gaeul Passage by 3 blinded SLPs; primary analysis was intention-to-treat ANCOVA adjusting for baseline intelligibility and age, with a prespecified noninferiority margin of –19 points.

Limitations

  • The paper states the sample was slightly below the planned size (73 vs 76), may be underpowered for secondary outcomes or subgroup effects, and lacked follow-up beyond the 4-week intervention.
  • The paper states generalizability is limited to cognitively intact, nonaphasic, smartphone-capable Korean speakers with predominantly mild-to-moderate dysarthria; comparator workbook therapy may not fully capture face-to-face SLP feedback, control adherence was self-reported, personalization differed between arms, and usability was assessed only in the intervention group.
  • The paper also notes high baseline intelligibility (median 89.00%) and a task-based passage-reading outcome may have limited measurement sensitivity and complicate interpretation of the 19-point noninferiority margin; the text makes evident an age imbalance favoring the younger intervention group.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2196/81938

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. CONSORT (Consolidated Standards of Reporting Trials) diagram.
Figure 1. CONSORT (Consolidated Standards of Reporting Trials) diagram.CC BY · PubMed Central
Figure 2. Speech intelligibility outcomes. (A) Speech intelligibility scores at baseline and postintervention for the intervention and control groups across all participants (score range: 0‐100); (B) Speech intelligibility scores for participants in the acute to early subacute stroke phase; (C). Speech intelligibility scores for participants in the chronic stroke phase; error bars represent standard errors.
Figure 2. Speech intelligibility outcomes. (A) Speech intelligibility scores at baseline and postintervention for the intervention and control groups across all participants (score range: 0‐100); (B) Speech intelligibility scores for participants in the acute to early subacute stroke phase; (C). Speech intelligibility scores for participants in the chronic stroke phase; error bars represent standard errors.CC BY · PubMed Central
Figure 3. Noninferiority analysis of the primary outcome adjusted mean differences (intervention minus control) with 95% CIs are shown for the intention-to-treat (ITT), per-protocol (PP), and ITT subgroup analyses by stroke phase. The dashed vertical line indicates the prespecified noninferiority margin (–19), and the solid vertical line indicates no difference. ITT: intention-to-treat.
Figure 3. Noninferiority analysis of the primary outcome adjusted mean differences (intervention minus control) with 95% CIs are shown for the intention-to-treat (ITT), per-protocol (PP), and ITT subgroup analyses by stroke phase. The dashed vertical line indicates the prespecified noninferiority margin (–19), and the solid vertical line indicates no difference. ITT: intention-to-treat.CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 18 Not checked · 125 Own results and interpretations

64 more claims

Create a free account to see all 149 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 38
  • Probably not a substantial claim. 53
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 49 references

Research works printed but not linked: 5

  1. Duffy JR . Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. 4th ed. Elsevier; 2020. ISBN: 9780323530545
  2. KIM, Journal of Korean Neuropsychiatric Association, 42, 124
  3. Isaacson, Am Fam Physician, 68, 1125
  4. Kim HH . Perceptual, acoustical, and physiological tools in ataxic dysarthria management: a case report. Presented at: Proceedings of the 2nd Conference of the Korean Society of Phonetic Sciences and Speech Technology; 9-22; Seoul, South Korea. 1996.URL: https://koreascience.kr/article/CFKO199613842057217.page [Accessed 08-05-2026]
  5. King, J Med Speech Lang Pathol, 20, 1

Metadata

Authors
Kim, Y., Kim, M., Kim, S., Kim, J., Shin, J.-H., Chang, Y., Na, J. Y., Kim, J., & Song, T.-J.
Affiliations
  • Yonsei University (KR)
  • National Rehabilitation Center (KR)
  • Ewha Womans University (KR)
  • Korea Nazarene University (KR)
Corresponding author
Song, Tae-Jin
Venue
Journal of Medical Internet Research
Published
2026-05-18
Volume
28
Pages
e81938-e81938
ISSN
1438-8871 (ISSN-L)
OpenAlex
W7161589653
Cited by
0
References
48
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Medical Internet Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research Foundation (BK21 FOUR)
  • Korea Health Industry Development Institute (RS-2023-00262087, NRF-5199990614253, HI22C073600)
  • National Research Foundation of Korea (NRF‐5199990614253, HI22C073600, 5199990614253, 2022-0-00621)
  • Ministry of Education, India
  • Ministry of Science and ICT, South Korea (2022-0-00621, BK21 FOUR, RS-2023)
  • Institute for Information and Communications Technology Promotion (2022-0-00621, 2022-)
Topics
  • Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
Keywords
speech intelligibility, non-inferiority, stroke rehabilitation, system usability, medication adherence, stroke survivors, quality of life, psychological well-being, speech function
MeSH terms
Smartphone, Aged, Dysarthria, Female, Humans, Male, Middle Aged, Speech Therapy, Single-Blind Method, Treatment Outcome, Stroke, Republic of Korea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.